imipenem, anhydrous has been researched along with Cardiovascular Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourra, B; Brun-Buisson, C; Gazaigne, L; Legrand, P; Lesprit, P; Renaud, B; Taillandier, E | 1 |
1 other study(ies) available for imipenem, anhydrous and Cardiovascular Diseases
Article | Year |
---|---|
Campylobacter fetus bloodstream infection: risk factors and clinical features.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Campylobacter fetus; Campylobacter Infections; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Imipenem; Immunocompromised Host; Male; Risk Factors; Treatment Outcome | 2008 |